{"gene":"PMCH","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1999,"finding":"Melanin-concentrating hormone (MCH) was identified as the natural ligand for the orphan G protein-coupled receptor SLC-1 (MCHR1). Using Xenopus oocytes injected with SLC-1 cRNA and GIRK channels, rat brain extracts were purified by cation exchange chromatography and HPLC; mass spectrometry and peptide sequencing confirmed MCH as the active peptide. The receptor couples to both Gi (GIRK-mediated currents) and Gq (phospholipase C / Ca2+-dependent Cl- currents) signaling pathways.","method":"Xenopus oocyte functional expression, HPLC purification, mass spectrometry, peptide sequencing, electrophysiology","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in functional expression system, biochemical purification, mass spectrometry identification, and two-pathway signaling validation in single study","pmids":["10471841"],"is_preprint":false},{"year":2001,"finding":"A second human MCH receptor (MCH-2R / MCH-R2) was identified and characterized. It shares ~38% amino acid identity with MCH-1R, binds MCH with high affinity, and signals exclusively through Gαq (inositol phosphate turnover and intracellular Ca2+ release) without sensitivity to pertussis toxin and without reducing cAMP, indicating it cannot couple to Gi.","method":"Receptor cloning, radioligand binding, intracellular Ca2+ assay, inositol phosphate assay, cAMP assay, pertussis toxin treatment, Northern blot, in situ hybridization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal signaling assays (IP, Ca2+, cAMP, pertussis toxin) in single study, replicated by at least two independent groups (PMID 11274220, 11459838)","pmids":["11404457","11274220","11459838"],"is_preprint":false},{"year":2001,"finding":"Structure-activity relationship studies of MCH at human MCHR1 (SLC-1) established that the minimal agonist sequence is MCH-(6-17) (the disulfide-bridged ring with flanking Arg6 and Trp17). Alanine scanning identified Met8, Arg11, and Tyr13 as essential residues for full potency. Deletion of ring residues produced inactivity or weak antagonists; replacement of the disulfide bridge by an amide bond was detrimental to agonist activity but produced weak antagonists.","method":"Synthetic peptide analogs, cAMP inhibition assay, [35S]-GTPγS binding, structure-activity relationship mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with 57 analogs tested across two independent functional assays (cAMP and GTPγS binding) in single comprehensive study","pmids":["11278733"],"is_preprint":false},{"year":1998,"finding":"Leptin signaling in the hypothalamus downregulates MCH gene expression, and central leptin administration completely prevents MCH-induced food intake in satiated rats, demonstrating that MCH acts downstream of leptin and that leptin blocks both the synthesis and post-synaptic action of MCH.","method":"Intracerebroventricular administration, in situ hybridization (gene expression), behavioral food intake measurements","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two independent studies (PMID 9449656, 9794487) using ICV pharmacology with gene expression and behavioral readouts, single lab","pmids":["9449656","9794487"],"is_preprint":false},{"year":2001,"finding":"MCH suppresses TSH release in vivo and in vitro via dual mechanisms: it reduces TRH release from hypothalamic explants and directly inhibits TRH-stimulated TSH release from dispersed pituitary cell cultures, placing MCH as an inhibitory regulator of the hypothalamic-pituitary-thyroid axis.","method":"ICV administration in rats (in vivo TSH measurement), hypothalamic explant TRH release assay, dispersed pituitary cell culture TSH release assay","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal in vitro/ex vivo systems (hypothalamic explants and pituitary cell cultures) plus in vivo pharmacology, single lab","pmids":["11416052"],"is_preprint":false},{"year":2003,"finding":"Chronic ICV infusion of MCH in mice increases lipogenic activity in WAT and liver and reduces thermogenesis markers (UCP-1, acyl-CoA oxidase, CPT-I mRNA) in brown adipose tissue independently of hyperphagia, establishing a direct role for MCH in promoting fat storage and reducing energy expenditure.","method":"Chronic ICV infusion, pair-feeding paradigm, lipogenic enzyme activity assays, mRNA expression analysis, rectal temperature measurement","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pair-fed controls isolate food-intake-independent metabolic effects; multiple metabolic readouts, single lab","pmids":["12554598"],"is_preprint":false},{"year":2004,"finding":"Using viral AAV-mediated GFP targeting of MCH neurons for identification in hypothalamic slices, monoaminergic arousal transmitters (norepinephrine, serotonin) and muscarinic acetylcholine agonist directly inhibit MCH neurons, NPY inhibits them by pre- and postsynaptic mechanisms, and hypocretin/orexin directly excites MCH neurons (inward current, increased spike frequency). Alpha-melanocortin agonist had no effect.","method":"AAV-GFP viral targeting, whole-cell patch clamp electrophysiology in hypothalamic slices, pharmacological agonist/antagonist application","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiological recordings with cell-type-specific identification, multiple transmitter systems tested with TTX controls, single lab with rigorous methods","pmids":["15157424"],"is_preprint":false},{"year":2010,"finding":"Glucose excitation of MCH neurons in the lateral hypothalamus is mediated by KATP channel closure (ATP-dependent), and this response is negatively regulated by UCP2 (a mitochondrial protein reducing ATP production). Cell-type-specific manipulation of glucose sensing in MCH neurons regulates peripheral glucose homeostasis.","method":"Conditional knockout (KATP channel and UCP2 deletion in MCH neurons), electrophysiology, glucose tolerance tests, insulin tolerance tests","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1 / Moderate — conditional genetic knockouts combined with electrophysiology and metabolic phenotyping, multiple orthogonal approaches, single lab","pmids":["21035764"],"is_preprint":false},{"year":2013,"finding":"Optogenetic activation of MCH neurons (10 Hz, channelrhodopsin-2) at the start of the night hastened sleep onset, reduced wake bout length by 50%, and increased total non-REM and REM sleep time, demonstrating that MCH neuronal activity is sufficient to promote sleep and counteract arousal neuron activity.","method":"Optogenetics (channelrhodopsin-2 AAV in MCH neurons), EEG/EMG polysomnography in freely moving mice","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — optogenetic cell-type-specific manipulation with objective sleep scoring, replicated by independent group (PMID 24828644)","pmids":["23785141"],"is_preprint":false},{"year":2014,"finding":"Acute optogenetic activation of MCH neurons during NREM sleep (but not wakefulness) induces transitions to REM sleep and increases REM sleep time while decreasing NREM sleep. Acute optogenetic silencing (archaerhodopsin-T) had no effect on vigilance states. Temporally controlled diphtheria toxin-mediated ablation of MCH neurons increased wakefulness and decreased NREM sleep without affecting REM sleep.","method":"Optogenetics (ChR2 E123T/T159C and archaerhodopsin-T knockin), cell-specific diphtheria toxin ablation, EEG/EMG polysomnography","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementary gain- and loss-of-function optogenetic approaches plus cell ablation, replicated activation finding across labs","pmids":["24828644"],"is_preprint":false},{"year":2013,"finding":"Ablation of MCH neurons (using diphtheria toxin targeted to the Pmch locus) in adult mice causes leanness, hyperactivity, and abnormal psychostimulant responses—phenotypes recapitulating MCH knockout—but also improved glucose tolerance that was not seen in MCH-deficient mice, establishing that MCH neurons regulate glucose tolerance through signaling molecules other than MCH itself.","method":"Diphtheria toxin receptor knockin at Pmch locus, ICV diphtheria toxin injection, metabolic phenotyping, glucose tolerance testing, locomotor activity monitoring","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean cell-type-specific ablation with comparison to MCH KO, multiple phenotypic readouts, single lab","pmids":["23365238"],"is_preprint":false},{"year":2015,"finding":"Optogenetic stimulation of orexin neurons inhibits action potential firing in most MCH neurons via GABAA receptors (not dynorphin receptors). Orexin cell firing increases the frequency of fast GABAergic currents in MCH cells via an effect blocked by orexin receptor antagonists but not dynorphin or glutamate receptor antagonists, and mimicked by bath-applied orexin peptide. A minority of MCH cells are excited by orexin peptides. This defines an intra-LH feedforward inhibitory microcircuit from orexin to MCH neurons.","method":"Optogenetics, whole-cell patch clamp, calcium imaging with genetically targeted indicator in MCH neurons, pharmacological receptor antagonism in mouse brain slices","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal electrophysiological and imaging approaches with pharmacological dissection of receptor mechanisms, single lab","pmids":["25855162"],"is_preprint":false},{"year":2016,"finding":"Fiberoptic calcium recordings from MCH neurons in awake freely moving mice show that MCH neurons generate conditional population bursts correlated with novelty exploration, inhibited by stress, and inversely predicted by orexin neuron activity. Brain-wide monosynaptic input mapping identified VGAT neurons in the amygdala and bed nucleus of stria terminalis as direct inhibitory controllers of MCH neurons, confirmed by optogenetic stimulation.","method":"Fiber photometry (GCaMP in MCH neurons), monosynaptic rabies virus tracing, optogenetics, freely moving awake recordings","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo cell-type-specific recordings combined with circuit mapping and optogenetic validation, multiple orthogonal methods","pmids":["27102565"],"is_preprint":false},{"year":2016,"finding":"Insulin activates MCH neurons via PI3K signaling; cell-type-specific deletion of the insulin receptor (IR) in MCH neurons in obese mice improves locomotor activity and insulin sensitivity. Acute chemogenetic (DREADD) activation of MCH neurons impairs locomotor activity but not insulin sensitivity, dissociating the two phenotypic effects.","method":"Conditional IR knockout in MCH neurons (IRΔMCH), immunostaining for phospho-Akt, DREADD chemogenetics, metabolic and locomotor phenotyping under normal and high-fat diet","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional genetic knockout and chemogenetics with multiple metabolic readouts, single lab","pmids":["27926856"],"is_preprint":false},{"year":2016,"finding":"Central CCL2 signaling acts on MCH neurons to mediate sickness behavior: MCH neurons express the CCL2 receptor (CCR2), and central CCL2 delivery decreases MCH neuronal electrical activity and MCH peptide release. Pharmacological or genetic inhibition of CCL2 signaling opposes LPS-induced decreases in MCH and body weight.","method":"Electrophysiology in MCH neurons, ex vivo MCH release measurement, CCL2 ICV delivery, CCR2 antagonism/genetic deletion, LPS model","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct electrophysiology showing CCL2 inhibits MCH neurons, combined with genetic and pharmacological loss-of-function, single lab","pmids":["27733491"],"is_preprint":false},{"year":2019,"finding":"MCH reduces POMC neuronal activity and acts through a SIRT1/FoxO1 signaling pathway in arcuate nucleus POMC neurons to induce hyperphagia, adiposity, and glucose intolerance. The orexigenic effects of MCH are independent of AgRP neurons (GABA-A receptor blockade in ARC did not prevent MCH-induced feeding; MCH silencing-induced hypophagia persisted after chemogenetic AgRP stimulation). Central SIRT1 mediates MCH-induced weight gain via effects on the sympathetic nervous system.","method":"Conditional SIRT1 knockout in POMC neurons, SIRT1 overexpression, ICV MCH administration, chemogenetic AgRP stimulation, electrophysiology of POMC neurons, GABA-A antagonism","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple conditional genetic models with pharmacological and chemogenetic approaches, single lab","pmids":["31530579"],"is_preprint":false},{"year":2020,"finding":"MCH neurons project densely to the median eminence (ME) in proximity to tanycytes and fenestrated vessels. Chemogenetic or optogenetic activation of MCH neuron projections in the ME increases ME permeability (fenestrated vascular loops) and enhances leptin action in the arcuate nucleus. MCH neurons express VEGFA, and blocking VEGF-R signaling attenuates the leptin-sensitizing effect of MCH neuron activation. Phospho-RiboTrap analysis identified endothelial cells as MCH-neuron-dependent targets.","method":"Chemogenetics (DREADD), optogenetics, unbiased phosphoRiboTrap cell-activation assay, vascular permeability assays, VEGF-R blockade, immunofluorescence","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal activation methods (chemogenetic and optogenetic), unbiased cell-activation screen, pharmacological receptor blockade with functional leptin sensitization readout, single lab","pmids":["32407670"],"is_preprint":false},{"year":2021,"finding":"Activation of the MCH system (via MCHR1 agonist, optogenetic or chemogenetic MCH neuron stimulation) shortens neuronal primary cilia (detected by ADCY3 marker quantification), while inactivation (pharmacological MCHR1 blockade, germline MCHR1 deletion, or conditional MCH neuron ablation) lengthens cilia, establishing a causal role of MCH signaling in regulating brain neuronal primary cilia length.","method":"Pharmacological MCHR1 agonist/antagonist, germline MCHR1 KO, conditional MCH neuron ablation, optogenetics, DREADD chemogenetics, quantitative ADCY3 immunofluorescence in organotypic brain slices and in vivo","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complementary gain- and loss-of-function approaches across multiple methods in single lab, functional readout (cilia length) is indirect marker","pmids":["34665407"],"is_preprint":false},{"year":2012,"finding":"Vasopressin and oxytocin directly excite MCH neurons (depolarization, increased spike frequency) in a TTX-resistant manner via V1aR and oxytocin receptors (confirmed by single-cell RT-PCR for V1aR and OTR mRNA in MCH cells). The vasopressin depolarization involves Na+/Ca2+ exchanger activation and opening of nonselective cation channels. These excitatory effects were absent in neighboring non-MCH GABA neurons (GAD67-GFP), indicating specificity.","method":"Whole-cell patch clamp in MCH-GFP and GAD67-GFP hypothalamic slices, Na+/Ca2+ exchanger blockers, BAPTA, ion substitution, single-cell RT-PCR","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiology with mechanistic ion channel/exchanger dissection, cell-type specificity confirmed, receptor identity confirmed by single-cell RT-PCR","pmids":["22262306"],"is_preprint":false},{"year":2000,"finding":"MCH receptor (SLC-1/MCHR1) mRNA and protein are expressed in insulin-producing cell lines (CRI-G1, RINm5F) and rat islets of Langerhans, with cell-surface receptor immunofluorescence. Rat MCH significantly stimulates insulin secretion from both cell lines, and this effect is potentiated by forskolin, suggesting MCH amplifies cAMP-dependent insulinotropic stimuli.","method":"RT-PCR, immunofluorescence, insulin secretion assay with forskolin co-treatment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor expression confirmed and functional insulin secretion assay with pharmacological modulation, single lab","pmids":["10964727"],"is_preprint":false},{"year":2008,"finding":"MCH knockout mice show elevated dopamine transporter (DAT) expression and enhanced DAT-mediated dopamine uptake in the nucleus accumbens, increased evoked dopamine release in the Acb shell, enhanced behavioral sensitization to amphetamine, and greater locomotor response to a DAT inhibitor, establishing that endogenous MCH signaling regulates mesolimbic dopamine system function.","method":"Immunoblotting for DAT, D1R, D2R; amperometry in ex vivo Acb slices; locomotor activity measurements after amphetamine and GBR 12909; catalepsy bar test; in situ hybridization","journal":"Biological psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and electrophysiological readouts in MCH KO vs. WT, single lab","pmids":["18281019"],"is_preprint":false},{"year":2009,"finding":"Pmch−/− rats are lean, hypophagic, and show reduced bone density. Body weight set point is determined predominantly during the first 8 postnatal weeks, and loss of Pmch during this developmental window establishes a 20% lower body weight set point that persists into adulthood, demonstrating that early developmental Pmch expression is critical for normal energy homeostasis programming.","method":"Rat Pmch knockout model, longitudinal body weight tracking, feeding behavior analysis, endocrine parameter measurements, calorimetry","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel knockout rat model with longitudinal phenotyping across developmental periods, single lab","pmids":["19934402"],"is_preprint":false},{"year":2008,"finding":"MCH modulates intestinal inflammatory responses: MCH and MCHR1 are upregulated in intestinal xenografts by C. difficile toxin A; MCH treatment of colonocytes upregulates IL-8 transcription; MCH-deficient mice show attenuated toxin A-induced intestinal inflammation and secretion; immunoneutralization of MCH or MCHR1 in wild-type mice similarly attenuates the response.","method":"Human intestinal xenograft model, RT-PCR, IL-8 transcriptional assay in colonocytes, MCH KO mice, immunoneutralization with anti-MCH and anti-MCHR1 antibodies, intestinal fluid secretion measurement","journal":"Gut","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and immunoneutralization loss-of-function with multiple tissue-level readouts, single lab","pmids":["18824554"],"is_preprint":false},{"year":1987,"finding":"In rat dorsolateral hypothalamus, MCH and alpha-MSH are co-localized in the same neuronal cell bodies and in the same dense core vesicles, as demonstrated by immunoelectron microscopy double-staining. In the human hypothalamus, MCH and alpha-MSH neurons do not co-localize.","method":"Immunofluorescence, peroxidase-anti-peroxidase immunocytochemistry, immunoelectron microscopy, double-staining","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ultrastructural immunoelectron microscopy provides direct evidence for co-storage in same secretory vesicles, single lab","pmids":["2823986"],"is_preprint":false},{"year":1997,"finding":"NK3 receptor (neurokinin B receptor) is immunocytochemically co-expressed on 57% of MCH neurons in the rat lateral hypothalamus and zona incerta, but not on neighboring prolactin-immunoreactive neurons, providing evidence that neurokinin B can regulate MCH neuronal activity via NK3 receptor.","method":"Immunocytochemistry, in situ hybridization for NK3 receptor, double-labeling with MCH and prolactin-ir neurons","journal":"Journal of chemical neuroanatomy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single immunohistochemical co-localization study, no functional validation of NK3-MCH neuron interaction, single lab","pmids":["9141650"],"is_preprint":false},{"year":2006,"finding":"MCH stimulates GH secretion from human fetal pituitary cultures and GH-secreting pituitary adenoma cells via MCH-R1 (but not MCH-R2, which is not expressed in these tissues). MCH treatment of GH adenoma cells induces ERK1/2 phosphorylation, indicating MCH-R1-mediated activation of MAP kinase signaling. Neuropeptide EI (co-encoded by the PMCH gene) also stimulates GH secretion from fetal pituitaries.","method":"GH secretion assay in human fetal pituitary cultures and GH adenoma cell cultures, RT-PCR for receptor expression, ERK1/2 phosphorylation immunoblot","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional GH secretion assay in human tissue with receptor identification and downstream signaling measurement, single lab","pmids":["16603725"],"is_preprint":false},{"year":1991,"finding":"In teleost melanocytes, MCH-induced melanosome aggregation is mediated via protein kinase C: phospholipase C inhibitors (4-bromophenacyl bromide, neomycin) shift the MCH dose-response curve; low-dose phorbol ester (TPA) mimics MCH pigment aggregation; PKC inhibitors (dibucaine, H-7) attenuate MCH effects. A protein dephosphorylation step is common to both MCH and norepinephrine lightening actions.","method":"In vitro eel skin melanocyte assay, pharmacological inhibitors of PLC and PKC, phorbol ester agonism, phosphatase inhibitor","journal":"Pigment cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological tools converging on PKC pathway in functional melanocyte assay, teleost model, single lab","pmids":["1946211"],"is_preprint":false},{"year":2018,"finding":"Sleep deprivation increases GLT1 apposition around MCH neuron somata, which functionally decreases the postsynaptic response of MCH neurons to high-frequency synaptic activation without changing presynaptic glutamate release. In contrast, GLT1 apposition around orexin neurons decreases after sleep deprivation. These changes reverse after sleep recovery, demonstrating astrocyte-mediated, state-dependent, cell-type-specific modulation of MCH neuron excitability.","method":"Quantitative immunohistochemistry for GLT1, whole-cell patch clamp in lateral hypothalamic slices, GLT1 inhibitor pharmacology, sleep deprivation and recovery paradigms in rats","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology combined with quantitative anatomical analysis and pharmacological GLT1 manipulation, single lab","pmids":["29431649"],"is_preprint":false},{"year":2020,"finding":"Selective deletion of oxytocin receptors from MCH neurons alters depressive behavior in a sex- and experience-dependent manner: increases depressive behavior in sexually naïve female mice, decreases it in late postpartum females, with no effect in sexually naïve males. The oxytocin-MCH pathway mediates the effects of sexual activity on depressive behavior, associated with changes in Arc (synaptic plasticity marker) expression in reward and fear circuits.","method":"Conditional oxytocin receptor knockout in MCH neurons (Cre-lox), forced swim test, Arc immunostaining, cohorts with defined mating/parenting history","journal":"Scientific reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — conditional KO with behavioral phenotyping and indirect synaptic plasticity marker; single lab, behavioral readout only without direct electrophysiology","pmids":["32788646"],"is_preprint":false},{"year":2005,"finding":"Both Pmch−/− and Mch1r−/− mice show enhanced voluntary running wheel activity compared to wild-type controls, establishing that endogenous MCH signaling plays an inhibitory role in regulating locomotor activity. Naloxone suppressed wheel running in both genotypes, indicating opioid regulation of locomotor activity operates independently of MCH.","method":"Running wheel monitoring in knockout mice, naloxone pharmacology, dynorphin mRNA measurement","journal":"Regulatory peptides","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two independent genetic models (Pmch KO and Mch1r KO) converge on same phenotype, single lab","pmids":["15544841"],"is_preprint":false},{"year":2010,"finding":"Microinjection of MCH into the dorsal raphe nucleus (DRN) elicits dose- and time-dependent depressive-like behavior (increased immobility in forced swim test) mediated by MCH-1 receptors (blocked by intra-DRN MCH-1R antagonist ATC0175). This effect is prevented by fluoxetine pretreatment and reversed by immunoneutralization of MCH within the DRN.","method":"Intra-DRN MCH microinjection, forced swim test, open field test, MCH-1R antagonist ATC0175, fluoxetine pretreatment, anti-MCH immunoneutralization","journal":"Behavioural brain research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological gain/loss-of-function in defined brain region, receptor-mediated effect confirmed, replicated across studies (PMID 25006977)","pmids":["21056060","25006977"],"is_preprint":false},{"year":1994,"finding":"The authentic human PMCH gene (encoding MCH, NEI, and NGE) is located on chromosome 12q23-q24 by Southern blot with somatic cell hybrids and FISH. Two variant MCH-like genes (PMCHL1 and PMCHL2) map to chromosomes 5p14 and 5q12-q13, respectively.","method":"Southern blotting with somatic cell hybrid panel, fluorescence in situ hybridization (FISH)","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two independent methods (somatic cell hybrids and FISH) for chromosomal localization, single lab","pmids":["8188237"],"is_preprint":false},{"year":2000,"finding":"The MCH gene in rats produces alternatively spliced transcripts: the precursor encoding MCH and neuropeptide EI (expressed in zona incerta/lateral hypothalamus), and a putative protein MGOP. MGOP co-localizes with MCH in 98% of LHA/ZI perikarya but has distinct projections to suprachiasmatic, ventromedial, arcuate nuclei, and median eminence external layer where MCH fibers are absent, and is expressed in additional non-MCH neurons.","method":"Northern blot, RT-PCR, in situ hybridization, Western blot (12 kDa protein), RP-HPLC + RIA, immunohistochemistry with MGOP-specific antiserum, COS7 cell transfection","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods confirming alternative PMCH gene product with distinct anatomical distribution, single lab","pmids":["11122347"],"is_preprint":false}],"current_model":"PMCH encodes the neuropeptide MCH (and co-peptides NEI, NGE, and MGOP from alternative splicing), which is synthesized primarily in lateral hypothalamic/zona incerta neurons and acts on two GPCRs—MCHR1 (Gi/Gq-coupled, expressed in rodents and humans) and MCHR2 (exclusively Gαq-coupled, expressed in humans/primates but not rodents)—to regulate energy homeostasis by promoting food intake, adipogenesis, and thermogenesis suppression via downstream signaling that includes SIRT1/FoxO1-mediated inhibition of POMC neurons; MCH neurons are also direct sleep-promoting cells (activated during/after sleep, optogenetic activation induces NREM-to-REM transitions and increases sleep), are inhibited by noradrenaline, serotonin, and via GABA-A-dependent orexin-driven feedforward circuits within the lateral hypothalamus, are excited by vasopressin/oxytocin through V1aR/Na+/Ca2+ exchanger mechanisms, are activated by glucose via KATP channels (modulated by UCP2), regulate mesolimbic dopamine signaling (MCH loss increases DAT expression and dopamine release in nucleus accumbens), modulate the HPT axis by suppressing TRH and TSH release, regulate median eminence vascular permeability via VEGFA to control leptin access to the arcuate nucleus, and control neuronal primary cilia length through MCHR1 signaling."},"narrative":{"mechanistic_narrative":"PMCH encodes the precursor for melanin-concentrating hormone (MCH) and the co-peptides neuropeptide EI (NEI), NGE, and MGOP generated by alternative splicing, synthesized in lateral hypothalamic/zona incerta neurons that establish a central node coordinating energy homeostasis, sleep, and behavioral state [PMID:19934402, PMID:11122347]. MCH is the cognate ligand for two G protein-coupled receptors: MCHR1, which couples to both Gi and Gq pathways [PMID:10471841], and the human-specific MCHR2, which signals exclusively through Gαq without coupling to Gi [PMID:11404457, PMID:11274220, PMID:11459838]; the minimal agonist core is the disulfide-bridged MCH-(6-17) ring, with Met8, Arg11, and Tyr13 essential for potency [PMID:11278733]. Through these receptors MCH promotes positive energy balance—it acts downstream of leptin, whose hypothalamic signaling suppresses MCH expression and action [PMID:9449656, PMID:9794487], drives lipogenesis in WAT/liver while reducing brown-fat thermogenesis independently of feeding [PMID:12554598], and induces hyperphagia and adiposity by inhibiting arcuate POMC neurons via a SIRT1/FoxO1 pathway [PMID:31530579]; loss of Pmch produces lean, hypophagic animals with a developmentally programmed lower body-weight set point [PMID:19934402]. MCH neurons themselves are an integrative sensor: directly excited by orexin in a minority of cells but predominantly inhibited by orexin through an intra-LH GABAergic feedforward microcircuit [PMID:15157424, PMID:25855162], excited by glucose via KATP-channel closure under UCP2 control [PMID:21035764], excited by vasopressin/oxytocin through V1aR/OTR and Na+/Ca2+ exchanger mechanisms [PMID:22262306], and inhibited by monoaminergic arousal transmitters [PMID:15157424]. Functionally, MCH neuron activity is sufficient to promote sleep and to drive NREM-to-REM transitions [PMID:23785141, PMID:24828644]. Beyond feeding and sleep, MCH neurons gate leptin access to the brain by raising median eminence vascular permeability via VEGFA [PMID:32407670], regulate mesolimbic dopamine by restraining DAT expression and dopamine release [PMID:18281019], suppress the hypothalamic-pituitary-thyroid axis [PMID:11416052], and control neuronal primary cilia length through MCHR1 signaling [PMID:34665407].","teleology":[{"year":1994,"claim":"Establishing the genomic identity and chromosomal location of the human PMCH gene anchored MCH biology to a defined locus distinct from variant MCH-like genes.","evidence":"Southern blotting with somatic cell hybrids and FISH localizing PMCH to 12q23-q24","pmids":["8188237"],"confidence":"Medium","gaps":["Did not address regulation of expression or the functional roles of variant PMCHL genes","No protein-level characterization of products"]},{"year":1987,"claim":"Demonstrating co-storage of MCH and alpha-MSH in the same dense-core vesicles in rat (but not human) hypothalamus established MCH as a vesicular neuropeptide with species-specific neuroanatomy.","evidence":"Immunoelectron microscopy double-staining in rat and human hypothalamus","pmids":["2823986"],"confidence":"Medium","gaps":["Did not establish functional consequence of co-storage","Species difference left mechanistically unexplained"]},{"year":2000,"claim":"Identification of alternatively spliced PMCH products (MCH/NEI precursor and MGOP) with distinct projection patterns revealed that the gene generates multiple peptides with divergent anatomy.","evidence":"Northern blot, RT-PCR, in situ hybridization, immunohistochemistry, and COS7 transfection in rat","pmids":["11122347"],"confidence":"Medium","gaps":["No receptor or function assigned to MGOP","Functional role of distinct MGOP projections unknown"]},{"year":1999,"claim":"Deorphanizing SLC-1/MCHR1 as the MCH receptor and showing dual Gi/Gq coupling defined the molecular machinery through which MCH signals.","evidence":"Xenopus oocyte functional expression, HPLC purification, mass spectrometry, electrophysiology","pmids":["10471841"],"confidence":"High","gaps":["Did not resolve which pathway dominates in native neurons","Cellular context of Gi versus Gq selection unaddressed"]},{"year":2001,"claim":"Cloning of human MCHR2 with exclusive Gαq coupling established a second, primate-relevant signaling arm of MCH biology and clarified receptor diversification, while SAR studies pinpointed the agonist pharmacophore.","evidence":"Receptor cloning with Ca2+/IP/cAMP/pertussis-toxin assays; synthetic analog cAMP and GTPγS assays for SAR","pmids":["11404457","11278733"],"confidence":"High","gaps":["Absence of functional MCHR2 in rodents limits in vivo dissection","In vivo physiological role of MCHR2 not established"]},{"year":1998,"claim":"Placing MCH downstream of leptin connected the peptide to the central energy-balance hierarchy.","evidence":"ICV leptin/MCH administration with in situ hybridization and food intake measurements in rats","pmids":["9449656","9794487"],"confidence":"Medium","gaps":["Molecular mechanism of leptin-driven Pmch repression unresolved","Pre- versus post-synaptic site of leptin block not separated"]},{"year":2003,"claim":"Showing MCH promotes lipogenesis and suppresses thermogenesis under pair-feeding established a feeding-independent metabolic role.","evidence":"Chronic ICV MCH infusion with pair-feeding, lipogenic enzyme and thermogenic mRNA assays in mice","pmids":["12554598"],"confidence":"Medium","gaps":["Receptor and neuronal circuit mediating peripheral effects not identified","Direct versus sympathetic mechanism not separated"]},{"year":2019,"claim":"Defining a SIRT1/FoxO1 pathway in POMC neurons that is AgRP-independent provided a discrete molecular mechanism for MCH-induced hyperphagia and adiposity.","evidence":"Conditional SIRT1 KO/overexpression in POMC neurons, ICV MCH, chemogenetic AgRP manipulation, electrophysiology","pmids":["31530579"],"confidence":"Medium","gaps":["Direct receptor on POMC neurons not defined","Link between POMC inhibition and sympathetic weight effects incompletely mapped"]},{"year":2004,"claim":"Cell-type-specific electrophysiology defined the afferent control logic of MCH neurons—monoaminergic and NPY inhibition versus orexin excitation.","evidence":"AAV-GFP targeting and whole-cell patch clamp in hypothalamic slices with pharmacology","pmids":["15157424"],"confidence":"High","gaps":["Did not resolve circuit-level (versus direct) effects in intact brain","Behavioral consequence of each input untested here"]},{"year":2010,"claim":"Identifying KATP-channel and UCP2-dependent glucose excitation of MCH neurons established them as metabolic sensors linked to peripheral glucose homeostasis.","evidence":"Conditional KATP/UCP2 deletion in MCH neurons, electrophysiology, glucose/insulin tolerance tests","pmids":["21035764"],"confidence":"High","gaps":["Downstream effectors translating glucose sensing to systemic glucose control unspecified","Relationship to feeding circuits not mapped"]},{"year":2012,"claim":"Demonstrating direct vasopressin/oxytocin excitation of MCH neurons via V1aR/OTR and Na+/Ca2+ exchange added a neurohypophyseal excitatory input with defined ionic mechanism.","evidence":"Patch clamp in MCH-GFP slices, Na+/Ca2+ exchanger blockers, ion substitution, single-cell RT-PCR","pmids":["22262306"],"confidence":"High","gaps":["Behavioral/physiological output of this input not tested","Source of endogenous peptide release onto MCH neurons unclear"]},{"year":2013,"claim":"Optogenetic activation showing MCH neurons promote sleep and ablation studies showing loss of MCH neurons recapitulates MCH-KO metabolic phenotypes (but additionally improves glucose tolerance) established both a sleep role and that MCH neurons act via co-released signals beyond MCH.","evidence":"ChR2 optogenetics with EEG/EMG polysomnography; Pmch-targeted diphtheria toxin ablation with metabolic phenotyping in mice","pmids":["23785141","23365238"],"confidence":"High","gaps":["Identity of the non-MCH glucose-regulating signal unknown","Target circuits for sleep promotion not defined here"]},{"year":2014,"claim":"State-dependent optogenetic manipulation refined the sleep role—MCH neuron activity during NREM drives NREM-to-REM transitions, with ablation selectively increasing wakefulness.","evidence":"Bidirectional optogenetics (ChR2, ArchT) and diphtheria toxin ablation with polysomnography","pmids":["24828644"],"confidence":"High","gaps":["Postsynaptic targets mediating REM induction not identified","Acute silencing had no effect, leaving necessity ambiguous"]},{"year":2015,"claim":"Mapping an intra-LH orexin-to-MCH GABAergic feedforward inhibitory microcircuit reconciled prior excitation findings and defined a wake/sleep arbitration circuit.","evidence":"Optogenetics, patch clamp, calcium imaging, and receptor antagonism in mouse slices","pmids":["25855162"],"confidence":"High","gaps":["Identity of the intermediary GABAergic neurons not fully defined","In vivo behavioral weight of this circuit not quantified"]},{"year":2016,"claim":"In vivo recording and input mapping defined MCH neurons as conditional burst-generating cells under amygdala/BNST inhibitory control, while insulin and CCL2 were established as additional modulators linking the neurons to metabolic state and sickness behavior.","evidence":"Fiber photometry, rabies tracing and optogenetics; conditional insulin-receptor KO with DREADDs; electrophysiology with CCR2 manipulation and LPS model","pmids":["27102565","27926856","27733491"],"confidence":"High","gaps":["Integration of these diverse modulatory inputs at the single-cell level unresolved","CCL2/insulin downstream signaling beyond initial nodes incomplete"]},{"year":2020,"claim":"Discovery that MCH neurons increase median eminence vascular permeability via VEGFA established a non-neuronal mechanism by which MCH neurons gate leptin access to the brain.","evidence":"Chemogenetic/optogenetic activation of ME projections, phosphoRiboTrap, VEGF-R blockade, permeability assays","pmids":["32407670"],"confidence":"High","gaps":["Whether VEGFA acts as a co-transmitter or via separate release not resolved","Long-term consequences for leptin sensitivity not assessed"]},{"year":2021,"claim":"Bidirectional manipulation showed MCH/MCHR1 signaling causally sets neuronal primary cilia length, linking the system to ciliary biology.","evidence":"MCHR1 agonist/antagonist, germline MCHR1 KO, MCH neuron ablation, optogenetics/DREADDs, ADCY3 immunofluorescence","pmids":["34665407"],"confidence":"Medium","gaps":["Cilia length measured via indirect ADCY3 marker","Downstream functional consequence of cilia-length change unknown"]},{"year":null,"claim":"How a single MCH signal is decoded into divergent outputs—sleep transitions, lipogenesis, leptin gating, dopamine modulation, and cilia regulation—across cell types and the in vivo role of MCHR2 remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking receptor coupling choice to specific physiological output","Rodent absence of MCHR2 limits in vivo dissection of human-relevant signaling"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[23]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,14]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,7,15]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,9,11]}],"complexes":[],"partners":["MCHR1","MCHR2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P20382","full_name":"Pro-MCH","aliases":[],"length_aa":165,"mass_kda":18.7,"function":"MCH may act as a neurotransmitter or neuromodulator in a broad array of neuronal functions directed toward the regulation of goal-directed behavior, such as food intake, and general arousal. May also have a role in spermatocyte differentiation","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P20382/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PMCH","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PMCH","total_profiled":1310},"omim":[{"mim_id":"614985","title":"HELLP SYNDROME-ASSOCIATED LONG NONCODING RNA; HELLPAR","url":"https://www.omim.org/entry/614985"},{"mim_id":"613687","title":"PARP1-BINDING PROTEIN; PARPBP","url":"https://www.omim.org/entry/613687"},{"mim_id":"606260","title":"MYOTUBULARIN-RELATED PROTEIN 9; MTMR9","url":"https://www.omim.org/entry/606260"},{"mim_id":"176795","title":"PRO-MELANIN-CONCENTRATING HORMONE; PMCH","url":"https://www.omim.org/entry/176795"},{"mim_id":"176794","title":"PRO-MELANIN-CONCENTRATING HORMONE-LIKE 2, PSEUDOGENE; PMCHL2","url":"https://www.omim.org/entry/176794"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"brain","ntpm":713.2}],"url":"https://www.proteinatlas.org/search/PMCH"},"hgnc":{"alias_symbol":["MCH"],"prev_symbol":[]},"alphafold":{"accession":"P20382","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P20382","model_url":"https://alphafold.ebi.ac.uk/files/AF-P20382-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P20382-F1-predicted_aligned_error_v6.png","plddt_mean":56.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PMCH","jax_strain_url":"https://www.jax.org/strain/search?query=PMCH"},"sequence":{"accession":"P20382","fasta_url":"https://rest.uniprot.org/uniprotkb/P20382.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P20382/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P20382"}},"corpus_meta":[{"pmid":"11370009","id":"PMC_11370009","title":"Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain.","date":"2001","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11370009","citation_count":302,"is_preprint":false},{"pmid":"10762350","id":"PMC_10762350","title":"The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat.","date":"2000","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10762350","citation_count":240,"is_preprint":false},{"pmid":"11404457","id":"PMC_11404457","title":"Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11404457","citation_count":204,"is_preprint":false},{"pmid":"23785141","id":"PMC_23785141","title":"Optogenetic stimulation of MCH neurons increases sleep.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23785141","citation_count":202,"is_preprint":false},{"pmid":"11274220","id":"PMC_11274220","title":"Molecular cloning and functional characterization of MCH2, a novel human MCH receptor.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11274220","citation_count":191,"is_preprint":false},{"pmid":"9449656","id":"PMC_9449656","title":"Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9449656","citation_count":189,"is_preprint":false},{"pmid":"15157424","id":"PMC_15157424","title":"Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection.","date":"2004","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15157424","citation_count":173,"is_preprint":false},{"pmid":"21035764","id":"PMC_21035764","title":"Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis.","date":"2010","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21035764","citation_count":167,"is_preprint":false},{"pmid":"15926928","id":"PMC_15926928","title":"Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors.","date":"2005","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15926928","citation_count":165,"is_preprint":false},{"pmid":"10471841","id":"PMC_10471841","title":"Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1).","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10471841","citation_count":163,"is_preprint":false},{"pmid":"24828644","id":"PMC_24828644","title":"Optogenetic manipulation of activity and temporally controlled cell-specific ablation reveal a role for MCH neurons in sleep/wake regulation.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24828644","citation_count":161,"is_preprint":false},{"pmid":"12554598","id":"PMC_12554598","title":"Characterization of MCH-mediated obesity in mice.","date":"2003","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12554598","citation_count":146,"is_preprint":false},{"pmid":"12954357","id":"PMC_12954357","title":"Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats.","date":"2003","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12954357","citation_count":145,"is_preprint":false},{"pmid":"16423919","id":"PMC_16423919","title":"Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16423919","citation_count":144,"is_preprint":false},{"pmid":"27102565","id":"PMC_27102565","title":"Awake dynamics and brain-wide direct inputs of hypothalamic MCH and orexin networks.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27102565","citation_count":140,"is_preprint":false},{"pmid":"11406287","id":"PMC_11406287","title":"Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus.","date":"2001","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11406287","citation_count":125,"is_preprint":false},{"pmid":"12620396","id":"PMC_12620396","title":"The structure and evolution of the melanocortin and MCH receptors in fish and mammals.","date":"2003","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12620396","citation_count":115,"is_preprint":false},{"pmid":"9794487","id":"PMC_9794487","title":"Leptin decreases food intake induced by melanin-concentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9794487","citation_count":113,"is_preprint":false},{"pmid":"12883265","id":"PMC_12883265","title":"Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets.","date":"2003","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/12883265","citation_count":104,"is_preprint":false},{"pmid":"12911757","id":"PMC_12911757","title":"Altered responses to orexigenic (AGRP, MCH) and anorexigenic (alpha-MSH, CART) neuropeptides of paraventricular hypothalamic neurons in early postnatally overfed rats.","date":"2003","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12911757","citation_count":101,"is_preprint":false},{"pmid":"25855162","id":"PMC_25855162","title":"Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25855162","citation_count":95,"is_preprint":false},{"pmid":"10683841","id":"PMC_10683841","title":"Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus.","date":"2000","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/10683841","citation_count":93,"is_preprint":false},{"pmid":"12890692","id":"PMC_12890692","title":"Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin.","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12890692","citation_count":86,"is_preprint":false},{"pmid":"11459838","id":"PMC_11459838","title":"Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, mch-r2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11459838","citation_count":84,"is_preprint":false},{"pmid":"19827161","id":"PMC_19827161","title":"Characterization of two melanin-concentrating hormone genes in zebrafish reveals evolutionary and physiological links with the mammalian MCH system.","date":"2009","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19827161","citation_count":79,"is_preprint":false},{"pmid":"11359525","id":"PMC_11359525","title":"Ontogenetic development of the diencephalic MCH neurons: a hypothalamic 'MCH area' hypothesis.","date":"2001","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11359525","citation_count":74,"is_preprint":false},{"pmid":"32038583","id":"PMC_32038583","title":"The Antifungal Peptide MCh-AMP1 Derived From Matricaria chamomilla Inhibits Candida albicans Growth via Inducing ROS Generation and Altering Fungal Cell Membrane Permeability.","date":"2020","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32038583","citation_count":73,"is_preprint":false},{"pmid":"11350801","id":"PMC_11350801","title":"Possible involvement of Rho kinase in Ca2+ sensitization and mobilization by MCh in tracheal smooth muscle.","date":"2001","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11350801","citation_count":67,"is_preprint":false},{"pmid":"32407670","id":"PMC_32407670","title":"MCH Neurons Regulate Permeability of the Median Eminence Barrier.","date":"2020","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/32407670","citation_count":66,"is_preprint":false},{"pmid":"18281019","id":"PMC_18281019","title":"Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18281019","citation_count":64,"is_preprint":false},{"pmid":"23365238","id":"PMC_23365238","title":"Ablation of neurons expressing melanin-concentrating hormone (MCH) in adult mice improves glucose tolerance independent of MCH signaling.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23365238","citation_count":60,"is_preprint":false},{"pmid":"15544841","id":"PMC_15544841","title":"Enhanced running wheel activity of both Mch1r- and Pmch-deficient mice.","date":"2005","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/15544841","citation_count":58,"is_preprint":false},{"pmid":"15752192","id":"PMC_15752192","title":"Genetic analysis of mch mutants in two Methanosarcina species demonstrates multiple roles for the methanopterin-dependent C-1 oxidation/reduction pathway and differences in H(2) metabolism between closely related species.","date":"2005","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15752192","citation_count":58,"is_preprint":false},{"pmid":"11416052","id":"PMC_11416052","title":"Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11416052","citation_count":58,"is_preprint":false},{"pmid":"27926856","id":"PMC_27926856","title":"Insulin-Dependent Activation of MCH Neurons Impairs Locomotor Activity and Insulin Sensitivity in Obesity.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27926856","citation_count":56,"is_preprint":false},{"pmid":"20582487","id":"PMC_20582487","title":"Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists.","date":"2010","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/20582487","citation_count":55,"is_preprint":false},{"pmid":"11278733","id":"PMC_11278733","title":"Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278733","citation_count":54,"is_preprint":false},{"pmid":"12550747","id":"PMC_12550747","title":"The MCH receptor family: feeding brain disorders?","date":"2003","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12550747","citation_count":53,"is_preprint":false},{"pmid":"22209364","id":"PMC_22209364","title":"The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior.","date":"2011","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22209364","citation_count":52,"is_preprint":false},{"pmid":"10964727","id":"PMC_10964727","title":"Expression of melanin-concentrating hormone receptors in insulin-producing cells: MCH stimulates insulin release in RINm5F and CRI-G1 cell-lines.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10964727","citation_count":51,"is_preprint":false},{"pmid":"26733789","id":"PMC_26733789","title":"Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression.","date":"2015","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26733789","citation_count":50,"is_preprint":false},{"pmid":"16443777","id":"PMC_16443777","title":"MCH-/- mice are resistant to aging-associated increases in body weight and insulin resistance.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16443777","citation_count":48,"is_preprint":false},{"pmid":"17226030","id":"PMC_17226030","title":"Feeding-induced changes of melanin-concentrating hormone (MCH)-like immunoreactivity in goldfish brain.","date":"2007","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/17226030","citation_count":47,"is_preprint":false},{"pmid":"15829220","id":"PMC_15829220","title":"Melanin concentrating hormone (MCH): a novel neural pathway for regulation of GnRH neurons.","date":"2005","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15829220","citation_count":46,"is_preprint":false},{"pmid":"27733491","id":"PMC_27733491","title":"Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation.","date":"2016","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/27733491","citation_count":45,"is_preprint":false},{"pmid":"21056060","id":"PMC_21056060","title":"Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test.","date":"2010","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21056060","citation_count":44,"is_preprint":false},{"pmid":"15363890","id":"PMC_15363890","title":"Increases in melanin-concentrating hormone and MCH receptor levels in the hypothalamus of dietary-obese rats.","date":"2004","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15363890","citation_count":43,"is_preprint":false},{"pmid":"2547205","id":"PMC_2547205","title":"Melanin-concentrating hormone (MCH) immunoreactivity in the brain and pituitary of the dogfish Scyliorhinus canicula. Colocalization with alpha-melanocyte-stimulating hormone (alpha-MSH) in hypothalamic neurons.","date":"1989","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/2547205","citation_count":42,"is_preprint":false},{"pmid":"29431649","id":"PMC_29431649","title":"Sleep Deprivation Distinctly Alters Glutamate Transporter 1 Apposition and Excitatory Transmission to Orexin and MCH Neurons.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29431649","citation_count":40,"is_preprint":false},{"pmid":"2779843","id":"PMC_2779843","title":"Human hypothalamic neuronal system revealed with a salmon melanin-concentrating hormone (MCH) antiserum.","date":"1989","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/2779843","citation_count":39,"is_preprint":false},{"pmid":"16257393","id":"PMC_16257393","title":"Effects of MCH and a MCH1-receptor antagonist on (palatable) food and water intake.","date":"2005","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16257393","citation_count":37,"is_preprint":false},{"pmid":"14706556","id":"PMC_14706556","title":"Increased susceptibility to LTP generation and changes in NMDA-NR1 and -NR2B subunits mRNA expression in rat hippocampus after MCH administration.","date":"2003","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/14706556","citation_count":37,"is_preprint":false},{"pmid":"19447150","id":"PMC_19447150","title":"Animals models of MCH function and what they can tell us about its role in energy balance.","date":"2009","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/19447150","citation_count":36,"is_preprint":false},{"pmid":"31530579","id":"PMC_31530579","title":"MCH Regulates SIRT1/FoxO1 and Reduces POMC Neuronal Activity to Induce Hyperphagia, Adiposity, and Glucose Intolerance.","date":"2019","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/31530579","citation_count":35,"is_preprint":false},{"pmid":"16870432","id":"PMC_16870432","title":"The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.","date":"2006","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/16870432","citation_count":35,"is_preprint":false},{"pmid":"19463877","id":"PMC_19463877","title":"Electrophysiological effects of MCH on neurons in the hypothalamus.","date":"2009","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/19463877","citation_count":34,"is_preprint":false},{"pmid":"31849590","id":"PMC_31849590","title":"The Melanin-Concentrating Hormone (MCH) System: A Tale of Two Peptides.","date":"2019","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31849590","citation_count":34,"is_preprint":false},{"pmid":"22262306","id":"PMC_22262306","title":"Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons.","date":"2012","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22262306","citation_count":34,"is_preprint":false},{"pmid":"19934402","id":"PMC_19934402","title":"Pmch expression during early development is critical for normal energy homeostasis.","date":"2009","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19934402","citation_count":32,"is_preprint":false},{"pmid":"8188237","id":"PMC_8188237","title":"Assignment of the human pro-melanin-concentrating hormone gene (PMCH) to chromosome 12q23-q24 and two variant genes (PMCH1 and PMCHL2) to chromosome 5p14 and 5q12-q13.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8188237","citation_count":32,"is_preprint":false},{"pmid":"15225734","id":"PMC_15225734","title":"Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.","date":"2004","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/15225734","citation_count":32,"is_preprint":false},{"pmid":"12808876","id":"PMC_12808876","title":"Prospects for obesity treatment: MCH receptor antagonists.","date":"2003","source":"Current opinion in investigational drugs (London, England : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12808876","citation_count":31,"is_preprint":false},{"pmid":"26410854","id":"PMC_26410854","title":"Correlation between blood rheological properties and red blood cell indices(MCH, MCV, MCHC) in healthy women.","date":"2016","source":"Clinical hemorheology and microcirculation","url":"https://pubmed.ncbi.nlm.nih.gov/26410854","citation_count":30,"is_preprint":false},{"pmid":"2823986","id":"PMC_2823986","title":"Melanin-concentrating hormone (MCH) is colocalized with alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat but not in the human hypothalamus.","date":"1987","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/2823986","citation_count":30,"is_preprint":false},{"pmid":"37058170","id":"PMC_37058170","title":"Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis.","date":"2023","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/37058170","citation_count":29,"is_preprint":false},{"pmid":"30155524","id":"PMC_30155524","title":"VGAT and VGLUT2 expression in MCH and orexin neurons in double transgenic reporter mice.","date":"2018","source":"IBRO reports","url":"https://pubmed.ncbi.nlm.nih.gov/30155524","citation_count":28,"is_preprint":false},{"pmid":"17324419","id":"PMC_17324419","title":"The melanin-concentrating hormone receptor 2 (MCH-R2) mediates the effect of MCH to control body color for background adaptation in the barfin flounder.","date":"2007","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17324419","citation_count":28,"is_preprint":false},{"pmid":"9141650","id":"PMC_9141650","title":"Immunocytochemical detection of the neurokinin B receptor (NK3) on melanin-concentrating hormone (MCH) neurons in rat brain.","date":"1997","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/9141650","citation_count":28,"is_preprint":false},{"pmid":"33828450","id":"PMC_33828450","title":"Orexin/Hypocretin and MCH Neurons: Cognitive and Motor Roles Beyond Arousal.","date":"2021","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33828450","citation_count":27,"is_preprint":false},{"pmid":"23414264","id":"PMC_23414264","title":"Oestradiol decreases melanin-concentrating hormone (MCH) and MCH receptor expression in the hypothalamus of female rats.","date":"2013","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23414264","citation_count":27,"is_preprint":false},{"pmid":"23941574","id":"PMC_23941574","title":"Empty iron stores in children and young adults--the diagnostic accuracy of MCV, MCH, and MCHC.","date":"2013","source":"International journal of laboratory hematology","url":"https://pubmed.ncbi.nlm.nih.gov/23941574","citation_count":27,"is_preprint":false},{"pmid":"34665407","id":"PMC_34665407","title":"Regulation of Brain Primary Cilia Length by MCH Signaling: Evidence from Pharmacological, Genetic, Optogenetic, and Chemogenic Manipulations.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34665407","citation_count":27,"is_preprint":false},{"pmid":"12503638","id":"PMC_12503638","title":"Expression of receptors for melanin-concentrating hormone (MCH) in different tissues and cell lines.","date":"2002","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/12503638","citation_count":25,"is_preprint":false},{"pmid":"1946211","id":"PMC_1946211","title":"Protein-kinase C mediates MCH signal transduction in teleost, synbranchus marmoratus, melanocytes.","date":"1991","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/1946211","citation_count":25,"is_preprint":false},{"pmid":"36393972","id":"PMC_36393972","title":"Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/36393972","citation_count":25,"is_preprint":false},{"pmid":"37674517","id":"PMC_37674517","title":"Orexin and MCH neurons: regulators of sleep and metabolism.","date":"2023","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37674517","citation_count":24,"is_preprint":false},{"pmid":"30335150","id":"PMC_30335150","title":"Melanin-Concentrating Hormone (MCH) and MCH-R1 in the Locus Coeruleus May Be Involved in the Regulation of Depressive-Like Behavior.","date":"2018","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30335150","citation_count":22,"is_preprint":false},{"pmid":"25006977","id":"PMC_25006977","title":"Prodepressive effect induced by microinjections of MCH into the dorsal raphe: time course, dose dependence, effects on anxiety-related behaviors, and reversion by nortriptyline.","date":"2014","source":"Behavioural pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25006977","citation_count":22,"is_preprint":false},{"pmid":"18410908","id":"PMC_18410908","title":"Melanin-concentrating hormone (MCH) immunoreactivity in non-neuronal cells within the raphe nuclei and subventricular region of the brainstem of the cat.","date":"2008","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18410908","citation_count":22,"is_preprint":false},{"pmid":"12182940","id":"PMC_12182940","title":"Cloning and characterization of rhesus monkey MCH-R1 and MCH-R2.","date":"2002","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/12182940","citation_count":21,"is_preprint":false},{"pmid":"9268615","id":"PMC_9268615","title":"Expression of MCH and POMC genes in rainbow trout (Oncorhynchus mykiss) during ontogeny and in response to early physiological challenges.","date":"1997","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9268615","citation_count":21,"is_preprint":false},{"pmid":"24140403","id":"PMC_24140403","title":"Melanin-concentrating hormone (MCH) and gonadotropin-releasing hormones (GnRH) in Atlantic cod, Gadus morhua: tissue distributions, early ontogeny and effects of fasting.","date":"2013","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/24140403","citation_count":21,"is_preprint":false},{"pmid":"8617278","id":"PMC_8617278","title":"Primary structure of cyclohydrolase (Mch) from Methanobacterium thermoautotrophicum (strain Marburg) and functional expression of the mch gene in Escherichia coli.","date":"1996","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8617278","citation_count":21,"is_preprint":false},{"pmid":"18824554","id":"PMC_18824554","title":"Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice.","date":"2008","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/18824554","citation_count":21,"is_preprint":false},{"pmid":"21945816","id":"PMC_21945816","title":"A preliminary investigation of the role of melanin-concentrating hormone (MCH) and its receptors in appetite regulation of winter flounder (Pseudopleuronectes americanus).","date":"2011","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21945816","citation_count":21,"is_preprint":false},{"pmid":"9357072","id":"PMC_9357072","title":"Melanin-concentrating hormone (MCH) involvement in pentylenetetrazole (PTZ)-induced seizure in rat and guinea pig.","date":"1997","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/9357072","citation_count":21,"is_preprint":false},{"pmid":"2755875","id":"PMC_2755875","title":"Melanin concentrating hormone (MCH): synthesis and bioactivity studies of MCH fragment analogues.","date":"1989","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/2755875","citation_count":20,"is_preprint":false},{"pmid":"11423380","id":"PMC_11423380","title":"Comparative analyses of the pigment-aggregating and -dispersing actions of MCH on fish chromatophores.","date":"2001","source":"Comparative biochemistry and physiology. Toxicology & pharmacology : CBP","url":"https://pubmed.ncbi.nlm.nih.gov/11423380","citation_count":20,"is_preprint":false},{"pmid":"32788646","id":"PMC_32788646","title":"Mating and parenting experiences sculpture mood-modulating effects of oxytocin-MCH signaling.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32788646","citation_count":19,"is_preprint":false},{"pmid":"30773822","id":"PMC_30773822","title":"Isolation, functional characterization, and biological properties of MCh-AMP1, a novel antifungal peptide from Matricaria chamomilla L.","date":"2019","source":"Chemical biology & drug design","url":"https://pubmed.ncbi.nlm.nih.gov/30773822","citation_count":19,"is_preprint":false},{"pmid":"19530577","id":"PMC_19530577","title":"Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.","date":"2009","source":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","url":"https://pubmed.ncbi.nlm.nih.gov/19530577","citation_count":19,"is_preprint":false},{"pmid":"17475262","id":"PMC_17475262","title":"Effects of background color on GnRH and MCH levels in the barfin flounder brain.","date":"2007","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17475262","citation_count":19,"is_preprint":false},{"pmid":"31121161","id":"PMC_31121161","title":"The role of Olfaction in MCH-regulated spontaneous maternal responses.","date":"2019","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31121161","citation_count":18,"is_preprint":false},{"pmid":"11021987","id":"PMC_11021987","title":"Characterization of [Phe(13), Tyr(19)]-MCH analog binding activity to the MCH receptor.","date":"2000","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/11021987","citation_count":18,"is_preprint":false},{"pmid":"19647772","id":"PMC_19647772","title":"MCH receptors/gene structure-in vivo expression.","date":"2009","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/19647772","citation_count":17,"is_preprint":false},{"pmid":"30791235","id":"PMC_30791235","title":"Plasticity for colour adaptation in vertebrates explained by the evolution of the genes pomc, pmch and pmchl.","date":"2019","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/30791235","citation_count":17,"is_preprint":false},{"pmid":"21818251","id":"PMC_21818251","title":"The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21818251","citation_count":17,"is_preprint":false},{"pmid":"16603725","id":"PMC_16603725","title":"Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.","date":"2006","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16603725","citation_count":17,"is_preprint":false},{"pmid":"17550369","id":"PMC_17550369","title":"Alcohol drinking in MCH receptor-1-deficient mice.","date":"2007","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/17550369","citation_count":16,"is_preprint":false},{"pmid":"11122347","id":"PMC_11122347","title":"Differential neuronal expression and projections of melanin-concentrating hormone (MCH) and MCH-gene-overprinted-polypeptide (MGOP) in the rat brain.","date":"2000","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11122347","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47124,"output_tokens":8882,"usd":0.137301,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19207,"output_tokens":5135,"usd":0.112205,"stage2_stop_reason":"end_turn"},"total_usd":0.249506,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Melanin-concentrating hormone (MCH) was identified as the natural ligand for the orphan G protein-coupled receptor SLC-1 (MCHR1). Using Xenopus oocytes injected with SLC-1 cRNA and GIRK channels, rat brain extracts were purified by cation exchange chromatography and HPLC; mass spectrometry and peptide sequencing confirmed MCH as the active peptide. The receptor couples to both Gi (GIRK-mediated currents) and Gq (phospholipase C / Ca2+-dependent Cl- currents) signaling pathways.\",\n      \"method\": \"Xenopus oocyte functional expression, HPLC purification, mass spectrometry, peptide sequencing, electrophysiology\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in functional expression system, biochemical purification, mass spectrometry identification, and two-pathway signaling validation in single study\",\n      \"pmids\": [\"10471841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A second human MCH receptor (MCH-2R / MCH-R2) was identified and characterized. It shares ~38% amino acid identity with MCH-1R, binds MCH with high affinity, and signals exclusively through Gαq (inositol phosphate turnover and intracellular Ca2+ release) without sensitivity to pertussis toxin and without reducing cAMP, indicating it cannot couple to Gi.\",\n      \"method\": \"Receptor cloning, radioligand binding, intracellular Ca2+ assay, inositol phosphate assay, cAMP assay, pertussis toxin treatment, Northern blot, in situ hybridization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal signaling assays (IP, Ca2+, cAMP, pertussis toxin) in single study, replicated by at least two independent groups (PMID 11274220, 11459838)\",\n      \"pmids\": [\"11404457\", \"11274220\", \"11459838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Structure-activity relationship studies of MCH at human MCHR1 (SLC-1) established that the minimal agonist sequence is MCH-(6-17) (the disulfide-bridged ring with flanking Arg6 and Trp17). Alanine scanning identified Met8, Arg11, and Tyr13 as essential residues for full potency. Deletion of ring residues produced inactivity or weak antagonists; replacement of the disulfide bridge by an amide bond was detrimental to agonist activity but produced weak antagonists.\",\n      \"method\": \"Synthetic peptide analogs, cAMP inhibition assay, [35S]-GTPγS binding, structure-activity relationship mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with 57 analogs tested across two independent functional assays (cAMP and GTPγS binding) in single comprehensive study\",\n      \"pmids\": [\"11278733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Leptin signaling in the hypothalamus downregulates MCH gene expression, and central leptin administration completely prevents MCH-induced food intake in satiated rats, demonstrating that MCH acts downstream of leptin and that leptin blocks both the synthesis and post-synaptic action of MCH.\",\n      \"method\": \"Intracerebroventricular administration, in situ hybridization (gene expression), behavioral food intake measurements\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two independent studies (PMID 9449656, 9794487) using ICV pharmacology with gene expression and behavioral readouts, single lab\",\n      \"pmids\": [\"9449656\", \"9794487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MCH suppresses TSH release in vivo and in vitro via dual mechanisms: it reduces TRH release from hypothalamic explants and directly inhibits TRH-stimulated TSH release from dispersed pituitary cell cultures, placing MCH as an inhibitory regulator of the hypothalamic-pituitary-thyroid axis.\",\n      \"method\": \"ICV administration in rats (in vivo TSH measurement), hypothalamic explant TRH release assay, dispersed pituitary cell culture TSH release assay\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal in vitro/ex vivo systems (hypothalamic explants and pituitary cell cultures) plus in vivo pharmacology, single lab\",\n      \"pmids\": [\"11416052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Chronic ICV infusion of MCH in mice increases lipogenic activity in WAT and liver and reduces thermogenesis markers (UCP-1, acyl-CoA oxidase, CPT-I mRNA) in brown adipose tissue independently of hyperphagia, establishing a direct role for MCH in promoting fat storage and reducing energy expenditure.\",\n      \"method\": \"Chronic ICV infusion, pair-feeding paradigm, lipogenic enzyme activity assays, mRNA expression analysis, rectal temperature measurement\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pair-fed controls isolate food-intake-independent metabolic effects; multiple metabolic readouts, single lab\",\n      \"pmids\": [\"12554598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Using viral AAV-mediated GFP targeting of MCH neurons for identification in hypothalamic slices, monoaminergic arousal transmitters (norepinephrine, serotonin) and muscarinic acetylcholine agonist directly inhibit MCH neurons, NPY inhibits them by pre- and postsynaptic mechanisms, and hypocretin/orexin directly excites MCH neurons (inward current, increased spike frequency). Alpha-melanocortin agonist had no effect.\",\n      \"method\": \"AAV-GFP viral targeting, whole-cell patch clamp electrophysiology in hypothalamic slices, pharmacological agonist/antagonist application\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiological recordings with cell-type-specific identification, multiple transmitter systems tested with TTX controls, single lab with rigorous methods\",\n      \"pmids\": [\"15157424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Glucose excitation of MCH neurons in the lateral hypothalamus is mediated by KATP channel closure (ATP-dependent), and this response is negatively regulated by UCP2 (a mitochondrial protein reducing ATP production). Cell-type-specific manipulation of glucose sensing in MCH neurons regulates peripheral glucose homeostasis.\",\n      \"method\": \"Conditional knockout (KATP channel and UCP2 deletion in MCH neurons), electrophysiology, glucose tolerance tests, insulin tolerance tests\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — conditional genetic knockouts combined with electrophysiology and metabolic phenotyping, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"21035764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Optogenetic activation of MCH neurons (10 Hz, channelrhodopsin-2) at the start of the night hastened sleep onset, reduced wake bout length by 50%, and increased total non-REM and REM sleep time, demonstrating that MCH neuronal activity is sufficient to promote sleep and counteract arousal neuron activity.\",\n      \"method\": \"Optogenetics (channelrhodopsin-2 AAV in MCH neurons), EEG/EMG polysomnography in freely moving mice\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — optogenetic cell-type-specific manipulation with objective sleep scoring, replicated by independent group (PMID 24828644)\",\n      \"pmids\": [\"23785141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Acute optogenetic activation of MCH neurons during NREM sleep (but not wakefulness) induces transitions to REM sleep and increases REM sleep time while decreasing NREM sleep. Acute optogenetic silencing (archaerhodopsin-T) had no effect on vigilance states. Temporally controlled diphtheria toxin-mediated ablation of MCH neurons increased wakefulness and decreased NREM sleep without affecting REM sleep.\",\n      \"method\": \"Optogenetics (ChR2 E123T/T159C and archaerhodopsin-T knockin), cell-specific diphtheria toxin ablation, EEG/EMG polysomnography\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementary gain- and loss-of-function optogenetic approaches plus cell ablation, replicated activation finding across labs\",\n      \"pmids\": [\"24828644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ablation of MCH neurons (using diphtheria toxin targeted to the Pmch locus) in adult mice causes leanness, hyperactivity, and abnormal psychostimulant responses—phenotypes recapitulating MCH knockout—but also improved glucose tolerance that was not seen in MCH-deficient mice, establishing that MCH neurons regulate glucose tolerance through signaling molecules other than MCH itself.\",\n      \"method\": \"Diphtheria toxin receptor knockin at Pmch locus, ICV diphtheria toxin injection, metabolic phenotyping, glucose tolerance testing, locomotor activity monitoring\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean cell-type-specific ablation with comparison to MCH KO, multiple phenotypic readouts, single lab\",\n      \"pmids\": [\"23365238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Optogenetic stimulation of orexin neurons inhibits action potential firing in most MCH neurons via GABAA receptors (not dynorphin receptors). Orexin cell firing increases the frequency of fast GABAergic currents in MCH cells via an effect blocked by orexin receptor antagonists but not dynorphin or glutamate receptor antagonists, and mimicked by bath-applied orexin peptide. A minority of MCH cells are excited by orexin peptides. This defines an intra-LH feedforward inhibitory microcircuit from orexin to MCH neurons.\",\n      \"method\": \"Optogenetics, whole-cell patch clamp, calcium imaging with genetically targeted indicator in MCH neurons, pharmacological receptor antagonism in mouse brain slices\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal electrophysiological and imaging approaches with pharmacological dissection of receptor mechanisms, single lab\",\n      \"pmids\": [\"25855162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Fiberoptic calcium recordings from MCH neurons in awake freely moving mice show that MCH neurons generate conditional population bursts correlated with novelty exploration, inhibited by stress, and inversely predicted by orexin neuron activity. Brain-wide monosynaptic input mapping identified VGAT neurons in the amygdala and bed nucleus of stria terminalis as direct inhibitory controllers of MCH neurons, confirmed by optogenetic stimulation.\",\n      \"method\": \"Fiber photometry (GCaMP in MCH neurons), monosynaptic rabies virus tracing, optogenetics, freely moving awake recordings\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo cell-type-specific recordings combined with circuit mapping and optogenetic validation, multiple orthogonal methods\",\n      \"pmids\": [\"27102565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Insulin activates MCH neurons via PI3K signaling; cell-type-specific deletion of the insulin receptor (IR) in MCH neurons in obese mice improves locomotor activity and insulin sensitivity. Acute chemogenetic (DREADD) activation of MCH neurons impairs locomotor activity but not insulin sensitivity, dissociating the two phenotypic effects.\",\n      \"method\": \"Conditional IR knockout in MCH neurons (IRΔMCH), immunostaining for phospho-Akt, DREADD chemogenetics, metabolic and locomotor phenotyping under normal and high-fat diet\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional genetic knockout and chemogenetics with multiple metabolic readouts, single lab\",\n      \"pmids\": [\"27926856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Central CCL2 signaling acts on MCH neurons to mediate sickness behavior: MCH neurons express the CCL2 receptor (CCR2), and central CCL2 delivery decreases MCH neuronal electrical activity and MCH peptide release. Pharmacological or genetic inhibition of CCL2 signaling opposes LPS-induced decreases in MCH and body weight.\",\n      \"method\": \"Electrophysiology in MCH neurons, ex vivo MCH release measurement, CCL2 ICV delivery, CCR2 antagonism/genetic deletion, LPS model\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct electrophysiology showing CCL2 inhibits MCH neurons, combined with genetic and pharmacological loss-of-function, single lab\",\n      \"pmids\": [\"27733491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCH reduces POMC neuronal activity and acts through a SIRT1/FoxO1 signaling pathway in arcuate nucleus POMC neurons to induce hyperphagia, adiposity, and glucose intolerance. The orexigenic effects of MCH are independent of AgRP neurons (GABA-A receptor blockade in ARC did not prevent MCH-induced feeding; MCH silencing-induced hypophagia persisted after chemogenetic AgRP stimulation). Central SIRT1 mediates MCH-induced weight gain via effects on the sympathetic nervous system.\",\n      \"method\": \"Conditional SIRT1 knockout in POMC neurons, SIRT1 overexpression, ICV MCH administration, chemogenetic AgRP stimulation, electrophysiology of POMC neurons, GABA-A antagonism\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple conditional genetic models with pharmacological and chemogenetic approaches, single lab\",\n      \"pmids\": [\"31530579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MCH neurons project densely to the median eminence (ME) in proximity to tanycytes and fenestrated vessels. Chemogenetic or optogenetic activation of MCH neuron projections in the ME increases ME permeability (fenestrated vascular loops) and enhances leptin action in the arcuate nucleus. MCH neurons express VEGFA, and blocking VEGF-R signaling attenuates the leptin-sensitizing effect of MCH neuron activation. Phospho-RiboTrap analysis identified endothelial cells as MCH-neuron-dependent targets.\",\n      \"method\": \"Chemogenetics (DREADD), optogenetics, unbiased phosphoRiboTrap cell-activation assay, vascular permeability assays, VEGF-R blockade, immunofluorescence\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal activation methods (chemogenetic and optogenetic), unbiased cell-activation screen, pharmacological receptor blockade with functional leptin sensitization readout, single lab\",\n      \"pmids\": [\"32407670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Activation of the MCH system (via MCHR1 agonist, optogenetic or chemogenetic MCH neuron stimulation) shortens neuronal primary cilia (detected by ADCY3 marker quantification), while inactivation (pharmacological MCHR1 blockade, germline MCHR1 deletion, or conditional MCH neuron ablation) lengthens cilia, establishing a causal role of MCH signaling in regulating brain neuronal primary cilia length.\",\n      \"method\": \"Pharmacological MCHR1 agonist/antagonist, germline MCHR1 KO, conditional MCH neuron ablation, optogenetics, DREADD chemogenetics, quantitative ADCY3 immunofluorescence in organotypic brain slices and in vivo\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complementary gain- and loss-of-function approaches across multiple methods in single lab, functional readout (cilia length) is indirect marker\",\n      \"pmids\": [\"34665407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Vasopressin and oxytocin directly excite MCH neurons (depolarization, increased spike frequency) in a TTX-resistant manner via V1aR and oxytocin receptors (confirmed by single-cell RT-PCR for V1aR and OTR mRNA in MCH cells). The vasopressin depolarization involves Na+/Ca2+ exchanger activation and opening of nonselective cation channels. These excitatory effects were absent in neighboring non-MCH GABA neurons (GAD67-GFP), indicating specificity.\",\n      \"method\": \"Whole-cell patch clamp in MCH-GFP and GAD67-GFP hypothalamic slices, Na+/Ca2+ exchanger blockers, BAPTA, ion substitution, single-cell RT-PCR\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiology with mechanistic ion channel/exchanger dissection, cell-type specificity confirmed, receptor identity confirmed by single-cell RT-PCR\",\n      \"pmids\": [\"22262306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MCH receptor (SLC-1/MCHR1) mRNA and protein are expressed in insulin-producing cell lines (CRI-G1, RINm5F) and rat islets of Langerhans, with cell-surface receptor immunofluorescence. Rat MCH significantly stimulates insulin secretion from both cell lines, and this effect is potentiated by forskolin, suggesting MCH amplifies cAMP-dependent insulinotropic stimuli.\",\n      \"method\": \"RT-PCR, immunofluorescence, insulin secretion assay with forskolin co-treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor expression confirmed and functional insulin secretion assay with pharmacological modulation, single lab\",\n      \"pmids\": [\"10964727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MCH knockout mice show elevated dopamine transporter (DAT) expression and enhanced DAT-mediated dopamine uptake in the nucleus accumbens, increased evoked dopamine release in the Acb shell, enhanced behavioral sensitization to amphetamine, and greater locomotor response to a DAT inhibitor, establishing that endogenous MCH signaling regulates mesolimbic dopamine system function.\",\n      \"method\": \"Immunoblotting for DAT, D1R, D2R; amperometry in ex vivo Acb slices; locomotor activity measurements after amphetamine and GBR 12909; catalepsy bar test; in situ hybridization\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and electrophysiological readouts in MCH KO vs. WT, single lab\",\n      \"pmids\": [\"18281019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pmch−/− rats are lean, hypophagic, and show reduced bone density. Body weight set point is determined predominantly during the first 8 postnatal weeks, and loss of Pmch during this developmental window establishes a 20% lower body weight set point that persists into adulthood, demonstrating that early developmental Pmch expression is critical for normal energy homeostasis programming.\",\n      \"method\": \"Rat Pmch knockout model, longitudinal body weight tracking, feeding behavior analysis, endocrine parameter measurements, calorimetry\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel knockout rat model with longitudinal phenotyping across developmental periods, single lab\",\n      \"pmids\": [\"19934402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MCH modulates intestinal inflammatory responses: MCH and MCHR1 are upregulated in intestinal xenografts by C. difficile toxin A; MCH treatment of colonocytes upregulates IL-8 transcription; MCH-deficient mice show attenuated toxin A-induced intestinal inflammation and secretion; immunoneutralization of MCH or MCHR1 in wild-type mice similarly attenuates the response.\",\n      \"method\": \"Human intestinal xenograft model, RT-PCR, IL-8 transcriptional assay in colonocytes, MCH KO mice, immunoneutralization with anti-MCH and anti-MCHR1 antibodies, intestinal fluid secretion measurement\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and immunoneutralization loss-of-function with multiple tissue-level readouts, single lab\",\n      \"pmids\": [\"18824554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"In rat dorsolateral hypothalamus, MCH and alpha-MSH are co-localized in the same neuronal cell bodies and in the same dense core vesicles, as demonstrated by immunoelectron microscopy double-staining. In the human hypothalamus, MCH and alpha-MSH neurons do not co-localize.\",\n      \"method\": \"Immunofluorescence, peroxidase-anti-peroxidase immunocytochemistry, immunoelectron microscopy, double-staining\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ultrastructural immunoelectron microscopy provides direct evidence for co-storage in same secretory vesicles, single lab\",\n      \"pmids\": [\"2823986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NK3 receptor (neurokinin B receptor) is immunocytochemically co-expressed on 57% of MCH neurons in the rat lateral hypothalamus and zona incerta, but not on neighboring prolactin-immunoreactive neurons, providing evidence that neurokinin B can regulate MCH neuronal activity via NK3 receptor.\",\n      \"method\": \"Immunocytochemistry, in situ hybridization for NK3 receptor, double-labeling with MCH and prolactin-ir neurons\",\n      \"journal\": \"Journal of chemical neuroanatomy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single immunohistochemical co-localization study, no functional validation of NK3-MCH neuron interaction, single lab\",\n      \"pmids\": [\"9141650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MCH stimulates GH secretion from human fetal pituitary cultures and GH-secreting pituitary adenoma cells via MCH-R1 (but not MCH-R2, which is not expressed in these tissues). MCH treatment of GH adenoma cells induces ERK1/2 phosphorylation, indicating MCH-R1-mediated activation of MAP kinase signaling. Neuropeptide EI (co-encoded by the PMCH gene) also stimulates GH secretion from fetal pituitaries.\",\n      \"method\": \"GH secretion assay in human fetal pituitary cultures and GH adenoma cell cultures, RT-PCR for receptor expression, ERK1/2 phosphorylation immunoblot\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional GH secretion assay in human tissue with receptor identification and downstream signaling measurement, single lab\",\n      \"pmids\": [\"16603725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"In teleost melanocytes, MCH-induced melanosome aggregation is mediated via protein kinase C: phospholipase C inhibitors (4-bromophenacyl bromide, neomycin) shift the MCH dose-response curve; low-dose phorbol ester (TPA) mimics MCH pigment aggregation; PKC inhibitors (dibucaine, H-7) attenuate MCH effects. A protein dephosphorylation step is common to both MCH and norepinephrine lightening actions.\",\n      \"method\": \"In vitro eel skin melanocyte assay, pharmacological inhibitors of PLC and PKC, phorbol ester agonism, phosphatase inhibitor\",\n      \"journal\": \"Pigment cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological tools converging on PKC pathway in functional melanocyte assay, teleost model, single lab\",\n      \"pmids\": [\"1946211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sleep deprivation increases GLT1 apposition around MCH neuron somata, which functionally decreases the postsynaptic response of MCH neurons to high-frequency synaptic activation without changing presynaptic glutamate release. In contrast, GLT1 apposition around orexin neurons decreases after sleep deprivation. These changes reverse after sleep recovery, demonstrating astrocyte-mediated, state-dependent, cell-type-specific modulation of MCH neuron excitability.\",\n      \"method\": \"Quantitative immunohistochemistry for GLT1, whole-cell patch clamp in lateral hypothalamic slices, GLT1 inhibitor pharmacology, sleep deprivation and recovery paradigms in rats\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology combined with quantitative anatomical analysis and pharmacological GLT1 manipulation, single lab\",\n      \"pmids\": [\"29431649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Selective deletion of oxytocin receptors from MCH neurons alters depressive behavior in a sex- and experience-dependent manner: increases depressive behavior in sexually naïve female mice, decreases it in late postpartum females, with no effect in sexually naïve males. The oxytocin-MCH pathway mediates the effects of sexual activity on depressive behavior, associated with changes in Arc (synaptic plasticity marker) expression in reward and fear circuits.\",\n      \"method\": \"Conditional oxytocin receptor knockout in MCH neurons (Cre-lox), forced swim test, Arc immunostaining, cohorts with defined mating/parenting history\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — conditional KO with behavioral phenotyping and indirect synaptic plasticity marker; single lab, behavioral readout only without direct electrophysiology\",\n      \"pmids\": [\"32788646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Both Pmch−/− and Mch1r−/− mice show enhanced voluntary running wheel activity compared to wild-type controls, establishing that endogenous MCH signaling plays an inhibitory role in regulating locomotor activity. Naloxone suppressed wheel running in both genotypes, indicating opioid regulation of locomotor activity operates independently of MCH.\",\n      \"method\": \"Running wheel monitoring in knockout mice, naloxone pharmacology, dynorphin mRNA measurement\",\n      \"journal\": \"Regulatory peptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two independent genetic models (Pmch KO and Mch1r KO) converge on same phenotype, single lab\",\n      \"pmids\": [\"15544841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Microinjection of MCH into the dorsal raphe nucleus (DRN) elicits dose- and time-dependent depressive-like behavior (increased immobility in forced swim test) mediated by MCH-1 receptors (blocked by intra-DRN MCH-1R antagonist ATC0175). This effect is prevented by fluoxetine pretreatment and reversed by immunoneutralization of MCH within the DRN.\",\n      \"method\": \"Intra-DRN MCH microinjection, forced swim test, open field test, MCH-1R antagonist ATC0175, fluoxetine pretreatment, anti-MCH immunoneutralization\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological gain/loss-of-function in defined brain region, receptor-mediated effect confirmed, replicated across studies (PMID 25006977)\",\n      \"pmids\": [\"21056060\", \"25006977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The authentic human PMCH gene (encoding MCH, NEI, and NGE) is located on chromosome 12q23-q24 by Southern blot with somatic cell hybrids and FISH. Two variant MCH-like genes (PMCHL1 and PMCHL2) map to chromosomes 5p14 and 5q12-q13, respectively.\",\n      \"method\": \"Southern blotting with somatic cell hybrid panel, fluorescence in situ hybridization (FISH)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two independent methods (somatic cell hybrids and FISH) for chromosomal localization, single lab\",\n      \"pmids\": [\"8188237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The MCH gene in rats produces alternatively spliced transcripts: the precursor encoding MCH and neuropeptide EI (expressed in zona incerta/lateral hypothalamus), and a putative protein MGOP. MGOP co-localizes with MCH in 98% of LHA/ZI perikarya but has distinct projections to suprachiasmatic, ventromedial, arcuate nuclei, and median eminence external layer where MCH fibers are absent, and is expressed in additional non-MCH neurons.\",\n      \"method\": \"Northern blot, RT-PCR, in situ hybridization, Western blot (12 kDa protein), RP-HPLC + RIA, immunohistochemistry with MGOP-specific antiserum, COS7 cell transfection\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods confirming alternative PMCH gene product with distinct anatomical distribution, single lab\",\n      \"pmids\": [\"11122347\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PMCH encodes the neuropeptide MCH (and co-peptides NEI, NGE, and MGOP from alternative splicing), which is synthesized primarily in lateral hypothalamic/zona incerta neurons and acts on two GPCRs—MCHR1 (Gi/Gq-coupled, expressed in rodents and humans) and MCHR2 (exclusively Gαq-coupled, expressed in humans/primates but not rodents)—to regulate energy homeostasis by promoting food intake, adipogenesis, and thermogenesis suppression via downstream signaling that includes SIRT1/FoxO1-mediated inhibition of POMC neurons; MCH neurons are also direct sleep-promoting cells (activated during/after sleep, optogenetic activation induces NREM-to-REM transitions and increases sleep), are inhibited by noradrenaline, serotonin, and via GABA-A-dependent orexin-driven feedforward circuits within the lateral hypothalamus, are excited by vasopressin/oxytocin through V1aR/Na+/Ca2+ exchanger mechanisms, are activated by glucose via KATP channels (modulated by UCP2), regulate mesolimbic dopamine signaling (MCH loss increases DAT expression and dopamine release in nucleus accumbens), modulate the HPT axis by suppressing TRH and TSH release, regulate median eminence vascular permeability via VEGFA to control leptin access to the arcuate nucleus, and control neuronal primary cilia length through MCHR1 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PMCH encodes the precursor for melanin-concentrating hormone (MCH) and the co-peptides neuropeptide EI (NEI), NGE, and MGOP generated by alternative splicing, synthesized in lateral hypothalamic/zona incerta neurons that establish a central node coordinating energy homeostasis, sleep, and behavioral state [#21, #32]. MCH is the cognate ligand for two G protein-coupled receptors: MCHR1, which couples to both Gi and Gq pathways [#0], and the human-specific MCHR2, which signals exclusively through Gαq without coupling to Gi [#1]; the minimal agonist core is the disulfide-bridged MCH-(6-17) ring, with Met8, Arg11, and Tyr13 essential for potency [#2]. Through these receptors MCH promotes positive energy balance—it acts downstream of leptin, whose hypothalamic signaling suppresses MCH expression and action [#3], drives lipogenesis in WAT/liver while reducing brown-fat thermogenesis independently of feeding [#5], and induces hyperphagia and adiposity by inhibiting arcuate POMC neurons via a SIRT1/FoxO1 pathway [#15]; loss of Pmch produces lean, hypophagic animals with a developmentally programmed lower body-weight set point [#21]. MCH neurons themselves are an integrative sensor: directly excited by orexin in a minority of cells but predominantly inhibited by orexin through an intra-LH GABAergic feedforward microcircuit [#6, #11], excited by glucose via KATP-channel closure under UCP2 control [#7], excited by vasopressin/oxytocin through V1aR/OTR and Na+/Ca2+ exchanger mechanisms [#18], and inhibited by monoaminergic arousal transmitters [#6]. Functionally, MCH neuron activity is sufficient to promote sleep and to drive NREM-to-REM transitions [#8, #9]. Beyond feeding and sleep, MCH neurons gate leptin access to the brain by raising median eminence vascular permeability via VEGFA [#16], regulate mesolimbic dopamine by restraining DAT expression and dopamine release [#20], suppress the hypothalamic-pituitary-thyroid axis [#4], and control neuronal primary cilia length through MCHR1 signaling [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing the genomic identity and chromosomal location of the human PMCH gene anchored MCH biology to a defined locus distinct from variant MCH-like genes.\",\n      \"evidence\": \"Southern blotting with somatic cell hybrids and FISH localizing PMCH to 12q23-q24\",\n      \"pmids\": [\"8188237\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not address regulation of expression or the functional roles of variant PMCHL genes\", \"No protein-level characterization of products\"]\n    },\n    {\n      \"year\": 1987,\n      \"claim\": \"Demonstrating co-storage of MCH and alpha-MSH in the same dense-core vesicles in rat (but not human) hypothalamus established MCH as a vesicular neuropeptide with species-specific neuroanatomy.\",\n      \"evidence\": \"Immunoelectron microscopy double-staining in rat and human hypothalamus\",\n      \"pmids\": [\"2823986\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish functional consequence of co-storage\", \"Species difference left mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of alternatively spliced PMCH products (MCH/NEI precursor and MGOP) with distinct projection patterns revealed that the gene generates multiple peptides with divergent anatomy.\",\n      \"evidence\": \"Northern blot, RT-PCR, in situ hybridization, immunohistochemistry, and COS7 transfection in rat\",\n      \"pmids\": [\"11122347\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No receptor or function assigned to MGOP\", \"Functional role of distinct MGOP projections unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Deorphanizing SLC-1/MCHR1 as the MCH receptor and showing dual Gi/Gq coupling defined the molecular machinery through which MCH signals.\",\n      \"evidence\": \"Xenopus oocyte functional expression, HPLC purification, mass spectrometry, electrophysiology\",\n      \"pmids\": [\"10471841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which pathway dominates in native neurons\", \"Cellular context of Gi versus Gq selection unaddressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Cloning of human MCHR2 with exclusive Gαq coupling established a second, primate-relevant signaling arm of MCH biology and clarified receptor diversification, while SAR studies pinpointed the agonist pharmacophore.\",\n      \"evidence\": \"Receptor cloning with Ca2+/IP/cAMP/pertussis-toxin assays; synthetic analog cAMP and GTPγS assays for SAR\",\n      \"pmids\": [\"11404457\", \"11278733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Absence of functional MCHR2 in rodents limits in vivo dissection\", \"In vivo physiological role of MCHR2 not established\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placing MCH downstream of leptin connected the peptide to the central energy-balance hierarchy.\",\n      \"evidence\": \"ICV leptin/MCH administration with in situ hybridization and food intake measurements in rats\",\n      \"pmids\": [\"9449656\", \"9794487\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of leptin-driven Pmch repression unresolved\", \"Pre- versus post-synaptic site of leptin block not separated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing MCH promotes lipogenesis and suppresses thermogenesis under pair-feeding established a feeding-independent metabolic role.\",\n      \"evidence\": \"Chronic ICV MCH infusion with pair-feeding, lipogenic enzyme and thermogenic mRNA assays in mice\",\n      \"pmids\": [\"12554598\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor and neuronal circuit mediating peripheral effects not identified\", \"Direct versus sympathetic mechanism not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defining a SIRT1/FoxO1 pathway in POMC neurons that is AgRP-independent provided a discrete molecular mechanism for MCH-induced hyperphagia and adiposity.\",\n      \"evidence\": \"Conditional SIRT1 KO/overexpression in POMC neurons, ICV MCH, chemogenetic AgRP manipulation, electrophysiology\",\n      \"pmids\": [\"31530579\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor on POMC neurons not defined\", \"Link between POMC inhibition and sympathetic weight effects incompletely mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Cell-type-specific electrophysiology defined the afferent control logic of MCH neurons—monoaminergic and NPY inhibition versus orexin excitation.\",\n      \"evidence\": \"AAV-GFP targeting and whole-cell patch clamp in hypothalamic slices with pharmacology\",\n      \"pmids\": [\"15157424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve circuit-level (versus direct) effects in intact brain\", \"Behavioral consequence of each input untested here\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying KATP-channel and UCP2-dependent glucose excitation of MCH neurons established them as metabolic sensors linked to peripheral glucose homeostasis.\",\n      \"evidence\": \"Conditional KATP/UCP2 deletion in MCH neurons, electrophysiology, glucose/insulin tolerance tests\",\n      \"pmids\": [\"21035764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors translating glucose sensing to systemic glucose control unspecified\", \"Relationship to feeding circuits not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating direct vasopressin/oxytocin excitation of MCH neurons via V1aR/OTR and Na+/Ca2+ exchange added a neurohypophyseal excitatory input with defined ionic mechanism.\",\n      \"evidence\": \"Patch clamp in MCH-GFP slices, Na+/Ca2+ exchanger blockers, ion substitution, single-cell RT-PCR\",\n      \"pmids\": [\"22262306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavioral/physiological output of this input not tested\", \"Source of endogenous peptide release onto MCH neurons unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Optogenetic activation showing MCH neurons promote sleep and ablation studies showing loss of MCH neurons recapitulates MCH-KO metabolic phenotypes (but additionally improves glucose tolerance) established both a sleep role and that MCH neurons act via co-released signals beyond MCH.\",\n      \"evidence\": \"ChR2 optogenetics with EEG/EMG polysomnography; Pmch-targeted diphtheria toxin ablation with metabolic phenotyping in mice\",\n      \"pmids\": [\"23785141\", \"23365238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the non-MCH glucose-regulating signal unknown\", \"Target circuits for sleep promotion not defined here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"State-dependent optogenetic manipulation refined the sleep role—MCH neuron activity during NREM drives NREM-to-REM transitions, with ablation selectively increasing wakefulness.\",\n      \"evidence\": \"Bidirectional optogenetics (ChR2, ArchT) and diphtheria toxin ablation with polysomnography\",\n      \"pmids\": [\"24828644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Postsynaptic targets mediating REM induction not identified\", \"Acute silencing had no effect, leaving necessity ambiguous\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapping an intra-LH orexin-to-MCH GABAergic feedforward inhibitory microcircuit reconciled prior excitation findings and defined a wake/sleep arbitration circuit.\",\n      \"evidence\": \"Optogenetics, patch clamp, calcium imaging, and receptor antagonism in mouse slices\",\n      \"pmids\": [\"25855162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the intermediary GABAergic neurons not fully defined\", \"In vivo behavioral weight of this circuit not quantified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"In vivo recording and input mapping defined MCH neurons as conditional burst-generating cells under amygdala/BNST inhibitory control, while insulin and CCL2 were established as additional modulators linking the neurons to metabolic state and sickness behavior.\",\n      \"evidence\": \"Fiber photometry, rabies tracing and optogenetics; conditional insulin-receptor KO with DREADDs; electrophysiology with CCR2 manipulation and LPS model\",\n      \"pmids\": [\"27102565\", \"27926856\", \"27733491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of these diverse modulatory inputs at the single-cell level unresolved\", \"CCL2/insulin downstream signaling beyond initial nodes incomplete\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that MCH neurons increase median eminence vascular permeability via VEGFA established a non-neuronal mechanism by which MCH neurons gate leptin access to the brain.\",\n      \"evidence\": \"Chemogenetic/optogenetic activation of ME projections, phosphoRiboTrap, VEGF-R blockade, permeability assays\",\n      \"pmids\": [\"32407670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether VEGFA acts as a co-transmitter or via separate release not resolved\", \"Long-term consequences for leptin sensitivity not assessed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Bidirectional manipulation showed MCH/MCHR1 signaling causally sets neuronal primary cilia length, linking the system to ciliary biology.\",\n      \"evidence\": \"MCHR1 agonist/antagonist, germline MCHR1 KO, MCH neuron ablation, optogenetics/DREADDs, ADCY3 immunofluorescence\",\n      \"pmids\": [\"34665407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cilia length measured via indirect ADCY3 marker\", \"Downstream functional consequence of cilia-length change unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single MCH signal is decoded into divergent outputs—sleep transitions, lipogenesis, leptin gating, dopamine modulation, and cilia regulation—across cell types and the in vivo role of MCHR2 remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking receptor coupling choice to specific physiological output\", \"Rodent absence of MCHR2 limits in vivo dissection of human-relevant signaling\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 7, 15]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 9, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MCHR1\", \"MCHR2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}